Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01908686 · ClinicalTrials.gov registry record · NA
Pivotal Response Treatment for Children With Autism Spectrum Disorders
A NA study of Autism Spectrum Disorders, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01908686: Completed NA study of Autism Spectrum Disorders, sponsored by Yale University.
NCT01908686 is a NA study of Autism Spectrum Disorders that has completed, run by Yale University. The registered enrollment target is 40 participants, below the 166-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01908686, a NA study of Autism Spectrum Disorders, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the application of an evidence-based, manualized treatment for children with Autism Spectrum Disorder (ASD) (Pivotal Response Treatment, PRT) to children ages four through six years of age with ASD. Specifically, children will be randomly assigned to receive either (1) 10 hours per week of intervention services, including two hours per week of parent education, and eight hours per week of direct clinician-delivered services, or (2) a treatment as usual control. Intervention will focus on enhancing the following developmental skills: expressive and receptive language, play, and social interaction. Outcome measures will address changes in the aforementioned domains during structured observation and standardized assessment.
Conditions Studied
Interventions
- BEHAVIORAL Pivotal Response Training
Study Locations (1)
Connecticut
- Yale Child Study Center - Autism Program - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-05 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
What the finished NCT01908686 record still lists
NCT01908686 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 166-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which Pivotal Response Training is the first listed.
NCT01908686 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01908686 about?
NCT01908686 is a clinical study titled "Pivotal Response Treatment for Children With Autism Spectrum Disorders". The purpose of this study is to evaluate the application of an evidence-based, manualized treatment for children with Autism Spectrum Disorder (ASD) (Pivotal Response Treatment, PRT) to children ages four through six years of age with ASD. Specifically, children will be randomly assigned to receive ...
What is the current status of trial NCT01908686?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-05. Estimated completion is 2020-03-01.
What conditions does trial NCT01908686 study?
This clinical trial studies the following conditions: Autism Spectrum Disorders.
What interventions are being tested in trial NCT01908686?
The interventions under investigation include: Pivotal Response Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01908686?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01908686 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01908686's enrollment target sits among peer trials
40 11th of 20 higher than 10 of 20 other Autism Spectrum Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Water Competency Intervention in Autism
RECRUITING · NA
-
Project AFECT (Autism Family Empowerment Coaching and Training Program)
ACTIVE NOT RECRUITING · NA
-
Telehealth Coaching for Families of Children With Autism
COMPLETED · NA
-
Screening and Linkage to Services for Autism
COMPLETED · NA
-
Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders
COMPLETED · NA
-
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia